Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.
Diffuse intrinsic pontine glioma (DIPG) is one of the most frequent malignant pediatric brain tumor and its prognosis is universaly fatal. No significant improvement has been made in last thirty years over the standard treatment with radiotherapy. To address the paucity of understanding of DIPGs, we...
Main Authors: | Stephanie Puget, Cathy Philippe, Dorine A Bax, Bastien Job, Pascale Varlet, Marie-Pierre Junier, Felipe Andreiuolo, Dina Carvalho, Ricardo Reis, Lea Guerrini-Rousseau, Thomas Roujeau, Philippe Dessen, Catherine Richon, Vladimir Lazar, Gwenael Le Teuff, Christian Sainte-Rose, Birgit Geoerger, Gilles Vassal, Chris Jones, Jacques Grill |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3289615?pdf=render |
Similar Items
-
CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
by: Christine Hoeman, et al.
Published: (2018-05-01) -
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
by: Matthieu Peyre, et al.
Published: (2010-09-01) -
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
by: Carman K. M. Ip, et al.
Published: (2018-11-01) -
An integrative radiological, histopathological and molecular analysis of pediatric pontine histone-wildtype glioma with MYCN amplification (HGG-MYCN)
by: A. Tauziède-Espariat, et al.
Published: (2019-06-01) -
Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
by: Sophie Huybrechts, et al.
Published: (2021-12-01)